Table 2 Outcomes according to treatment
Variable | NaCl group | Oxymetazoline group | P-value |
|---|---|---|---|
Congestion (%) | 2 (25.0) | 3 (37.5) | 1.000 |
Pain (%) | 1 (12.5) | 1 (12.5) | 1.000 |
Epistaxis (%) | 2 (25.0) | 4 (50.0) | 0.608 |
Success (%) | 6 (75.0.) | 6 (75.0) | 1.000 |
Day 2 outcomes | |||
Patency (%) | 7 (87.5) | 7 (87.5) | 1.000 |
Tube in Place (%) | 7 (87.5) | 7 (87.5) | 1.000 |
Granuloma formed (%) | 1 (12.5) | 1 (12.5) | 1.000 |
With bleeding (%) | 1 (12.5) | 1 (12.5) | 1.000 |
Day 16 outcomes | |||
Patency (%) | 7 (87.5) | 7 (87.5) | 1.000 |
Tube in place (%) | 7 (87.5) | 7 (87.5) | 1.000 |
Granuloma formed (%) | 1 (12.5) | 1 (12.5) | 1.000 |
With bleeding (%) | 1 (12.5) | 1 (12.5) | 1.000 |